1[1]Gulliford,Epsteim R.Endocrine treatment of cancer.JR Soc Med,1996,89(8):448～453.
2[2]Komminoth P,Kunz EK,Matias-Guiu X,et al.Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.Cancer,1995,76:479～489.
3[3]Kamik PS,Kulkami S,Liu X,et al.Estrogen receptor mutations in tamoxifen resistant breast cancer.Cancer Res,1994,54:349～353.
4[4]Fuqua SAW,Wolf DM Molecular aspects of estrogen receptor variants breast cancen Breast Cancer Res Trea.1995,35(3):233～241.
5[5]Ottaviano YL,Issa JP,Parl FF,et al.Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.Cancer Res,1994,54(10):2 552～2 556.
6[6]Tokunaga A,Kojima N,Andoh T,et al.Hormone receptors in gastiric cancer.Eur J Cancer Clin Oncol,1 983,19(5):687～690.
7[7]Tokunage A,Nishi K,Matsukura N.et al.Estrogen and progesterone receptors in gastric cancen Cancer,1 986,57:1376.
9Gragn ET, Ingle JN, Ahmann DL, et al. Phase study of high dose tamoxifen (NSC - 180973 )in patients with disseminated malignant melanoma. Cancer, 1982,49:1353.
10Mirimanoff RO, Wagenknecht L, Hunziker N. long- term complete remission of malignant melanoma with tamoxifen,lancet, 1981,1 : 1368.
5Marc L,Guy L.The"portrait"of hereditary breat cancer[J].Breat Cancer Res and Trea,2005,(89):297-304.
6Jones PA,Baylin S B.The fundamental role of ep igenetic events incancer[J].Nat Rev Genet,2002,(3):415-428.
7Imogen L,Zs Ofia KJ,Elizabeth B,et al.Loss of heter ozygosity at the BRCA1 and BRCA2 loci deteced in ductal lavage fluid from BRCA gene mutati on carriers and contr ols[J].Cancer Epidemiol Biomarkers Prev,2006,7(15):1399-1402.
8Trachtenberg J G M S C.A phase 3,multicenter,open label,randomized study of abarelix versus leuprolide pius daily antiandrogen in men with prostate cancer[J].J Urol,2002,(167):1670-1674.
9Lonning PE.Clinico-pharmacilogical aspects of different horm one treatment[J].Eur J Cancer,2000,14(36):81-82.
10Howe IIA,Cuzick J,B aum M,et al.Results of the ATAC(Arim idex,Tam ox ifen,Alone or and Comb ination)trialaftercom pletion of 5 years adjuvant treatment for breats cancer[J].Lancet,2005,(365):60-62.
